Analyses through the TCGA melanoma data set supported an increased mRNA expression of DDX3X, EIF1AC, GNL3L, and RBMX in skin or lymph node metastases, but with no significant correlation with overall patient survival (Supplementary Table 2). This evidence concerns the gene RBMX and melanoma.